학술논문

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
Document Type
Article
Source
In Annals of Oncology February 2019 30(2):317-324
Subject
Language
ISSN
0923-7534